Suppression of established hepatocarcinoma in adjuvant only immunotherapy: alum triggers anti-tumor CD8(+) T cell response

Dendritic cell-based immunotherapy is a new weapon in our battle against malignancies in human. Recent trials in human and research work in model animals have shown various degrees of success, suggesting its great potential for clinical use. While protocols vary, a common scheme in this category of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bo, Wang, Xuanyi, Wen, Yumei, Fu, Jing, Wang, Hongyang, Ma, Zhangmei, Shi, Yan, Wang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673419/
https://www.ncbi.nlm.nih.gov/pubmed/26647964
http://dx.doi.org/10.1038/srep17695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673419/
https://www.ncbi.nlm.nih.gov/pubmed/26647964
http://dx.doi.org/10.1038/srep17695

Ejemplares similares